Australia markets closed

JBM (Healthcare) Limited (2161.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.8800.000 (0.00%)
At close: 02:59PM HKT

JBM (Healthcare) Limited

Unit 808-811
C-Bons International Centre, 8th Floor 108 Wai Yip Street
Kwun Tong
Hong Kong
852 2267 2182
https://www.jbmhealthcare.com.hk

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees258

Key executives

NameTitlePayExercisedYear born
Mr. Yat Wai WongCEO & Executive Director2.81MN/A1963
Mr. Kau Lap LamVP of FinanceN/AN/A1986
Ms. Hoi Ki LeungOperation ManagerN/AN/A1982
Ms. Chui Yee LoSenior Marketing ManagerN/AN/A1969
Dr. Heung Kwan ChengExecutive DirectorN/AN/A1962
Mr. Chun Kau Yu ACS, FCPACompany SecretaryN/AN/A1973
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded, healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other nonpharmaceutical products for the general health and wellness of consumers. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.

Corporate governance

JBM (Healthcare) Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.